
DOI . ORG {
}
Title[redir]:
Autoimmune Inflammatory Myopathy after Treatment with Ipilimumab | Canadian Journal of Neurological Sciences | Cambridge Core
Description:
Autoimmune Inflammatory Myopathy after Treatment with Ipilimumab - Volume 36 Issue 4
Matching Content Categories {📚}
- Health & Fitness
- Education
- Science
Content Management System {📝}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, but we identified it was custom coded using Nuxt.js (JavaScript).
Traffic Estimate {📈}
What is the average monthly size of doi.org audience?
🏙️ Massive Traffic: 50M - 100M visitors per month
Based on our best estimate, this website will receive around 76,079,999 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {💸}
We're unsure if the website is profiting.
Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org might be plotting its profit, but the way they're doing it isn't detectable yet.
Keywords {🔍}
scholar, crossrefgoogle, oncol, abstract, cambridge, google, clin, scholarpubmed, content, canadian, journal, neurological, autoimmune, treatment, blockade, melanoma, antigen, antibody, cookies, sciences, pdf, copyright, ctla, cancer, phan, autoimmunity, regression, patients, phase, antictla, proc, susceptibility, accessibility, products, services, open, journals, volume, issue, inflammatory, myopathy, article, references, ipilimumab, online, university, press, robinson, save, rights,
Topics {✒️}
immune-related adverse events anti-ctla-4 antibody ipilimumab cambridge university press services register log anti-cytotoxic tlymphocyte antigen-4 neurological sciences canadian journal human anti-ctla-4 discover content products 1017/s0317167100007939 [opens ann surg oncol cytotoxic t-lymphocyte full pdf main content accessibility soc clin oncol autoimmune disease metastatic melanoma treated robinson anti-cytotoxic antibody blockade [abstract] proc window] abstract crossrefgoogle scholarpubmed ctla4 blockade information type clin oncol accept cookies cookie settings chris voll volume 36 issue 4 malignant melanoma tumor regression lopez-berestein antitumor activity antiself responses /ii study case studies clinical response penha-goncalves apoptosis resistance legal notices patients treated ctla-4 cancer invest cancer regression access 88 cited autoimmunity correlates abstract antigen 4
Social Networks {👍}(5)
External Links {🔗}(87)
- How profitable is https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/#maincontent?
- Earnings of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/accessibility
- What is the earnings of https://www.cambridge.org/about-us/legal-notices/cookies-policy/?
- What are the total earnings of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/#?
- How much profit does https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/login?ref=/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C make?
- How much money does https://www.cambridge.org/academic make?
- Revenue of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/shopping-cart
- https://www.cambridge.org/core/register's total income per month
- How much does https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/login pull in?
- Discover the revenue of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/
- Earnings of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core
- What's the revenue for https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/publications/journals?
- What's the total monthly financial gain of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/journals/canadian-journal-of-neurological-sciences?
- Learn how profitable https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/journals/canadian-journal-of-neurological-sciences/issue/B1108E29B3D2C621DE757FBB83B6E4EB is on a monthly basis
- Check the income stats for https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/#sec0
- https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/#references-list's revenue stream
- What is the earnings of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/search?filters%5BauthorTerms%5D=Gary%20Hunter&eventCode=SE-AU?
- What are the earnings of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/search?filters%5BauthorTerms%5D=Chris%20Voll&eventCode=SE-AU?
- What's the financial intake of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/search?filters%5BauthorTerms%5D=Christopher%20A.%20Robinson&eventCode=SE-AU?
- Get to know what's the income of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/#authors-details
- https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/#appTabs income
- Learn about the earnings of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/#article-tab
- What's https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/#metrics-tab's gross income?
- Revenue of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/#toc-list-mobile
- Earnings of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/services/aop-cambridge-core/content/view/94F7F75CC4E689493BB0C92883152D1C/S0317167100007939a.pdf/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab.pdf
- How much does https://s100.copyright.com/AppDispatchServlet?publisherName=CUP&publication=CJN&title=Autoimmune%20Inflammatory%20Myopathy%20after%20Treatment%20with%20Ipilimumab&publicationDate=02%20December%202014&author=Gary%20Hunter%2C%20Chris%20Voll%2C%20Christopher%20A.%20Robinson©right=The%20Canadian%20Journal%20of%20Neurological%202009&contentID=10.1017%2FS0317167100007939&startPage=518&endPage=520&orderBeanReset=True&volumeNum=36&issueNum=4&oa= rake in every month?
- How much does https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/journals/canadian-journal-of-neurological-sciences/volume/435C05709598B2A1266F8F73F310EEE1 earn?
- How much does https://scholar.google.com/scholar_lookup?title=The+role+of+the+CTLA4+blockade+in+the+treatment+of+malignant+melanoma&author=Cranmer+LD&author=Hersh+E.&publication+year=2007&journal=Cancer+Invest.&volume=25&pages=613-31 make?
- Discover the revenue of https://scholar.google.com/scholar_lookup?title=Autoimmunity+correlates+with+tumor+regression+in+patients+with+metastatic+melanoma+treated+with+anti-cytotoxic+Tlymphocyte+antigen-4&author=Attia+P&author=Phan+GQ&author=Maker+AV&author=Robinson+MR&author=Quezado+MM&author=Yang+JC&publication+year=2005&journal=J+Clin+Oncol.&volume=23&doi=10.1200%2FJCO.2005.06.205&pages=6043-53
- What's the financial intake of https://www.ncbi.nlm.nih.gov/pubmed/16087944?
- How much does https://scholar.google.com/scholar_lookup?title=Antitumor+activity+in+melanoma+and+antiself+responses+in+a+phase+I+trial+with+the+anti-cytotoxic+T+lymphocyte-associated+antigen+4+monoclonal+antibody+CP-675%2C206&author=Ribas+A&author=Camacho+LH&author=Lopez-Berestein+G&author=Pavlov+D&author=Bulanhagui+CA&author=Millham+R&publication+year=2005&journal=J+Clin+Oncol.&volume=23&doi=10.1200%2FJCO.2005.01.109&pages=8968-77 earn?
- How much revenue does https://scholar.google.com/scholar_lookup?title=MDX-010+(human+anti-CTLA-4)%3A+a+phase+I+trial+in+malignant+melanoma&author=Tchekmedyian+S&author=Glasby+J&author=Korman+A&author=Keler+T&author=Deo+Y&author=Davis+T.&publication+year=2002&journal=Proc+Am+Soc+Clin+Oncol.&volume=2 generate?
- How much revenue does https://scholar.google.com/scholar_lookup?title=Blockade+of+CTLA-4+with+MDX-010+in+humans+can+induce+both+autoimmunity+and+cancer+regression&author=Phan+GQ&author=Haworth+LR&author=Duray+PH&author=Davis+TA&author=Rosenberg+SA.&publication+year=2003&journal=Proc+Am+Soc+Clin+Oncol.&volume=22 bring in?
- https://scholar.google.com/scholar_lookup?title=Tumor+regression+and+autoimmunity+in+patients+treated+with+cytotoxic+T+lymphocyteassociated+antigen+4+blockade+and+interleukin+2%3A+a+phase+I%2FII+study&author=Maker+AV&author=Phan+GQ&author=Attia+P&author=Yang+JC&author=Sherry+RM&author=Topalian+SL&publication+year=2005&journal=Ann+Surg+Oncol.&volume=12&doi=10.1245%2FASO.2005.03.536&pages=1005-16's financial summary
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/pubmed/16283570?
- Revenue of https://scholar.google.com/scholar_lookup?title=Review%3A+Anti-CTLA-4+Antibody+Ipilimumab%3A+case+studies+of+clinical+response+and+immune-related+adverse+events&author=Weber+J.&publication+year=2007&journal=The+Oncologist.&volume=12&doi=10.1634%2Ftheoncologist.12-7-864&pages=864-72
- What's the monthly income of https://www.ncbi.nlm.nih.gov/pubmed/17673617?
- What's the revenue for https://scholar.google.com/scholar_lookup?title=Enterocolitis+in+patients+with+cancer+after+antibody+blockade+of+cytotoxic+T-lymphocyte+associated+antigen+4&author=Beck+KE&author=Blansfield+JA&author=Tran+KQ&author=Feldman+AL&author=Hughes+MS&author=Royal+RE&publication+year=2006&journal=J+Clin+Oncol.&volume=24&pages=2283-9?
- How much money does https://scholar.google.com/scholar_lookup?title=Apoptosis+resistance+of+nonobese+diabetic+peripheral+lymphocytes+linked+to+the+Idd5+diabetes+susceptibility+region&author=Colucci+F&author=Bergman+ML&author=Penha-Goncalves+C&author=Cilio+CM&author=Holmberg+D.&publication+year=1997&journal=Proc+Natl+Acad+Sci+USA.&volume=94&pages=8670-4 make?
- Monthly income for https://scholar.google.com/scholar_lookup?title=The+diabetes+susceptibility+locus+Idd5.1+on+mouse+chromosome+1+regulates+ICOS+expression+and+modulates+murine+experimental+autoimmune+encephalomyelitis&author=Greve+B&author=Vijayakrishnan+L&author=Kubal+A&author=Sobel+RA&author=Peterson+LB&author=Wicker+LS&publication+year=2004&journal=J+Immunol.&volume=73&doi=10.4049%2Fjimmunol.173.1.157&pages=157-63
- Financial intake of https://scholar.google.com/scholar_lookup?title=Association+of+the+T-cell+regulatory+gene+CTLA4+with+susceptibility+to+autoimmune+disease&author=Ueda+H&author=Howson+JM&author=Esposito+L.&publication+year=2003&journal=Nature.&volume=423&doi=10.1038%2Fnature01621&pages=506-11
- How much profit is https://www.ncbi.nlm.nih.gov/pubmed/12724780 making per month?
- How much income is https://scholar.google.com/scholar_lookup?title=Anti-CTLA-4+antibody+treatment+triggers+determinant+spreading+and+enhances+murine+myasthenia+gravis&author=Wang+HB&author=Shi+FD&author=Li+H&author=Chambers+BJ&author=Link+H&author=Ljunggren+HG.&publication+year=2001&journal=J+Immunol.&volume=166&doi=10.4049%2Fjimmunol.166.10.6430&pages=6430-6 earning monthly?
- Find out how much https://www.ncbi.nlm.nih.gov/pubmed/11342669 earns monthly
- Learn about the earnings of http://www.crossref.org/citedby/index.html
- Get to know https://scholar.google.com/scholar_lookup?title=Current+World+Literature&&publication_year=2010's earnings
- How profitable is https://scholar.google.com/scholar_lookup?title=Ipilimumab:+Unleashing+the+Power+of+the+Immune+System+Through+CTLA-4+Blockade&author=Boasberg+Peter&author=Hamid+Omid&author=O’Day+Steven&publication_year=2010?
- How much does https://scholar.google.com/scholar_lookup?title=The+Emerging+Toxicity+Profiles+of+Anti–CTLA-4+Antibodies+Across+Clinical+Indications&author=Di+Giacomo+Anna+Maria&author=Biagioli+Maurizio&author=Maio+Michele&publication_year=2010 pull in?
- Get to know what's the income of https://scholar.google.com/scholar_lookup?title=Radiologic+Manifestations+of+Immune-Related+Adverse+Events+in+Patients+With+Metastatic+Melanoma+Undergoing+Anti–CTLA-4+Antibody+Therapy&author=Bronstein+Yulia&author=Ng+Chaan+S.&author=Hwu+Patrick&author=Hwu+Wen-Jen&publication_year=2011
- What are the earnings of https://scholar.google.com/scholar_lookup?title=Radiologic+Aspects+of+Immune-Related+Tumor+Response+Criteria+and+Patterns+of+Immune-Related+Adverse+Events+in+Patients+Undergoing+Ipilimumab+Therapy&author=O'Regan+Kevin+N.&author=Jagannathan+Jyothipriya+P.&author=Ramaiya+Nikhil&author=Hodi+F.+Stephen&publication_year=2011?
- What's the financial outcome of https://scholar.google.com/scholar_lookup?title=Severe+meningo-radiculo-nevritis+associated+with+ipilimumab&author=Bompaire+Flavie&author=Mateus+Christine&author=Taillia+Hervé&author=De+Greslan+Thierry&author=Lahutte+Marion&author=Sallansonnet-Froment+Magali&author=Ouologuem+Madani&author=Renard+Jean-Luc&author=Gorochov+Guy&author=Robert+Caroline&author=Ricard+Damien&publication_year=2012?
- How much does https://scholar.google.com/scholar_lookup?title=Ipilimumab+in+melanoma&author=Specenier+Pol&publication_year=2012 gross monthly?
- How much income does https://scholar.google.com/scholar_lookup?title=The+Price+of+Tumor+Control:+An+Analysis+of+Rare+Side+Effects+of+Anti-CTLA-4+Therapy+in+Metastatic+Melanoma+from+the+Ipilimumab+Network&author=Voskens+Caroline+J.&author=Goldinger+Simone+M.&author=Loquai+Carmen&author=Robert+Caroline&author=Kaehler+Katharina+C.&author=Berking+Carola&author=Bergmann+Tanja&author=Bockmeyer+Clemens+L.&author=Eigentler+Thomas&author=Fluck+Michael&author=Garbe+Claus&author=Gutzmer+Ralf&author=Grabbe+Stephan&author=Hauschild+Axel&author=Hein+Rüdiger&author=Hundorfean+Gheorghe&author=Justich+Armin&author=Keller+Ullrich&author=Klein+Christina&author=Mateus+Christine&author=Mohr+Peter&author=Paetzold+Sylvie&author=Satzger+Imke&author=Schadendorf+Dirk&author=Schlaeppi+Marc&author=Schuler+Gerold&author=Schuler-Thurner+Beatrice&author=Trefzer+Uwe&author=Ulrich+Jens&author=Vaubel+Julia&author=von+Moos+Roger&author=Weder+Patrik&author=Wilhelm+Tabea&author=Göppner+Daniela&author=Dummer+Reinhard&author=Heinzerling+Lucie+M.&author=Soyer+H.+Peter&publication_year=2013 have?
- How much does https://scholar.google.com/scholar_lookup?title=Cancer+Immunotherapy&author=Callahan+Margaret+K.&author=Postow+Michael+A.&author=Wolchok+Jedd+D.&publication_year=2013 earn?
- How much does https://scholar.google.com/scholar_lookup?title=Immune-Mediated+Adverse+Events+Associated+with+Ipilimumab+CTLA-4+Blockade+Therapy:+The+Underlying+Mechanisms+and+Clinical+Management&author=Tarhini+Ahmad&publication_year=2013 bring in each month?
- What's the profit of https://scholar.google.com/scholar_lookup?title=Multifocal+radiculoneuropathy+during+ipilimumab+treatment+of+melanoma&author=Manousakis+Georgios&author=Koch+James&author=Sommerville+R.+Brian&author=El‐Dokla+Ahmed&author=Harms+Matthew+B.&author=Al‐Lozi+Muhammad+T.&author=Schmidt+Robert+E.&author=Pestronk+Alan&publication_year=2013?
- https://scholar.google.com/scholar_lookup?title=Experience+in+daily+practice+with+ipilimumab+for+the+treatment+of+patients+with+metastatic+melanoma:+an+early+increase+in+lymphocyte+and+eosinophil+counts+is+associated+with+improved+survival&author=Delyon+J.&author=Mateus+C.&author=Lefeuvre+D.&author=Lanoy+E.&author=Zitvogel+L.&author=Chaput+N.&author=Roy+S.&author=Eggermont+A.M.M.&author=Routier+E.&author=Robert+C.&publication_year=2013's total income per month
- Monthly income for https://scholar.google.com/scholar_lookup?title=Immunomodulatory+therapy+for+melanoma:+Ipilimumab+and+beyond&author=Callahan+Margaret+K.&author=Postow+Michael+A.&author=Wolchok+Jedd+D.&publication_year=2013
- What's the financial outcome of https://scholar.google.com/scholar_lookup?title=Ipilimumab+and+Its+Toxicities:+A+Multidisciplinary+Approach&author=Fecher+Leslie+A.&author=Agarwala+Sanjiv+S.&author=Hodi+F.+Stephen&author=Weber+Jeffrey+S.&publication_year=2013?
- https://scholar.google.com/scholar_lookup?title=Atypical+neurological+complications+of+ipilimumab+therapy+in+patients+with+metastatic+melanoma&author=Liao+B.&author=Shroff+S.&author=Kamiya-Matsuoka+C.&author=Tummala+S.&publication_year=2014's financial summary
- How much does https://scholar.google.com/scholar_lookup?title=Abeloff's+Clinical+Oncology&author=Yust-Katz+Shlomit&author=Gilbert+Mark+R.&publication_year=2014 net monthly?
- Explore the financials of https://scholar.google.com/scholar_lookup?title=Immune+related+adverse+events+associated+with+anti-CTLA-4+antibodies:+systematic+review+and+meta-analysis&author=Bertrand+Anne&author=Kostine+Marie&author=Barnetche+Thomas&author=Truchetet+Marie-Elise&author=Schaeverbeke+Thierry&publication_year=2015
- How much does https://scholar.google.com/scholar_lookup?title=Ipilimumab+in+melanoma&author=Specenier+Pol&publication_year=2016 rake in every month?
- How much does https://scholar.google.com/scholar_lookup?title=Metastatic+melanoma:+Pathologic+characterization+current+treatment+and+complications+of+therapy&author=Wick+Mark+R.&author=Gru+Alejandro+A.&publication_year=2016 gross monthly?
- Find out how much https://scholar.google.com/scholar_lookup?title=A+New+Look+at+Toxicity+in+the+Era+of+Precision+Oncology:+Imaging+Findings+Their+Relationship+With+Tumor+Response+and+Effect+on+Metastasectomy&author=Howard+Stephanie+A.+Holler&author=Krajewski+Katherine+M.&author=Jagannathan+Jyothi+P.&author=Braschi-Amirfarzan+Marta&author=Tirumani+Sree+H.&author=Shinagare+Atul+B.&author=Ramaiya+Nikhil+H.&publication_year=2016 earns monthly
- How much profit does https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/services/aop-cambridge-core/download/cited-by?doi=10.1017/S0317167100007939&productType=JOURNAL_ARTICLE&productId=94F7F75CC4E689493BB0C92883152D1C make?
- How much income does https://scholar.google.com/scholar?hl=en&lr=&cites=https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C have?
- What's the profit of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/?
- Profit of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/help/FAQs
- How much profit does https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/legal-notices/terms generate?
- Earnings of https://www.cambridge.org/core/
- What's the financial gain of https://www.cambridge.org/engage/coe/public-dashboard?
- How much money does https://www.cambridge.org/highereducation/ make?
- Discover the revenue of https://www.cambridge.org/core/publications/journals
- What is the monthly revenue of https://www.cambridge.org/core/search?aggs%5BproductTypes%5D%5Bfilters%5D=BOOK?
- https://www.cambridge.org/core/publications/elements's total income per month
- How much profit does https://www.cambridge.org/highereducation/search?aggs=%24productTypes%24BOOK%3Atrue%3B%3B generate?
- How much cash flow does https://www.cambridge.org/highereducation/search?aggs=%24productTypes%24COURSEWARE%3Atrue%3B%3B have monthly?
- How much profit does https://www.cambridge.org/about-us/rights-permissions/ make?
- Find out how much https://www.cambridge.org/about-us/legal-notices/copyright/ earns monthly
- How much revenue does https://www.cambridge.org/about-us/legal-notices/privacy-policy/ produce monthly?
- How much income is https://www.cambridge.org/about-us/legal-notices/terms-use earning monthly?
- What is the earnings of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/help?
- How much does https://www.amazon.com/gp/help/customer/display.html/ref=kinw_myk_wl_ln?ie=UTF8&nodeId=200767340#fees make?
- How profitable is https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/search?filters%5BauthorTerms%5D=Gary Hunter&eventCode=SE-AU?
- Get to know what's the income of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/search?filters%5BauthorTerms%5D=Chris Voll&eventCode=SE-AU
- Revenue of https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/autoimmune-inflammatory-myopathy-after-treatment-with-ipilimumab/94F7F75CC4E689493BB0C92883152D1C/core/search?filters%5BauthorTerms%5D=Christopher A. Robinson&eventCode=SE-AU
Analytics and Tracking {📊}
- Google Analytics
- Google Analytics 4
- Google Tag Manager
- Google Universal Analytics
- Hotjar
Libraries {📚}
- FontAwesome
- Foundation
- jQuery
- Modernizr
- Slick
- Video.js
Emails and Hosting {✉️}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {📦}
- Shareaholic